Share

April 2015; 2 (2) Clinical/Scientific NotesOpen Access

Complement-associated neuronal loss in a patient with CASPR2 antibody–associated encephalitis

Peter Körtvelyessy, Jan Bauer, Christian M. Stoppel, Wolfgang Brück, Ivonne Gerth, Stefan Vielhaber, Falk R. Wiedemann, Hans J. Heinze, Claudius Bartels, Christian G. Bien
First published February 12, 2015, DOI: https://doi.org/10.1212/NXI.0000000000000075
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
982

Share

Article Information

vol. 2 no. 2 e75
DOI: 
https://doi.org/10.1212/NXI.0000000000000075
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received September 19, 2014
  • Accepted in final form December 30, 2014
  • First Published February 12, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Peter Körtvelyessy, MD*,
    2. Jan Bauer, PhD*,
    3. Christian M. Stoppel, MD, PhD,
    4. Wolfgang Brück, MD,
    5. Ivonne Gerth, MA,
    6. Stefan Vielhaber, MD,
    7. Falk R. Wiedemann, MD,
    8. Hans J. Heinze, MD,
    9. Claudius Bartels, MD and
    10. Christian G. Bien, MD
  1. Peter Körtvelyessy, MD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Jan Bauer, PhD*,
    3. Scientific Advisory Boards:

    1. SAB of the dutch foundation for Multiple Sclerosis research (non-profit entity)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Dept of Neuroimmunology, Center for Brain Research. Medical University of Vienna. Associate Professor

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Christian M. Stoppel, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Wolfgang Brück, MD,
    5. Scientific Advisory Boards:

    1. I serve on the advisory board of Genzyme, Novartis, Biogen Idec Germany and Teva Pharma.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. I received honoraria for oral presentations from Teva, Sanofi, Genzyme, Novartis, Merck-Serono, Biogen Idec and Bayer in the last 2 years.

    Editorial Boards:

    1. I am editorial board member of Acta neuropathologica, Therapeutic Advances in Neurological disorders, Multiple Sclerosis International and Neuropathology and Applied Neurobiology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. German Research foundation (DFG SFB TR43): The brain as a target of inflammatory processes, 2008-2015 German ministry for science and education: Competence network multiple sclerosis, 2010-2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Tschira Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Ivonne Gerth, MA,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Stefan Vielhaber, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Falk R. Wiedemann, MD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Hans J. Heinze, MD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Claudius Bartels, MD and
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Christian G. Bien, MD
    11. Scientific Advisory Boards:

    1. Serving on a scientific advisory board for Eisai and UCB, Germany Travel funded by a commercial entity: Grifols, UCB, Eisai, GlaxoSmithKline, Desitin Honoraria for speaking engagements from Desitin, GlaxoSmithKline, UCB, Eisai

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Commercial entities: UCB Pharma, Desitin Pharma, Eisai Pharma, biogen idec, Fresenius Medical Care, diamed -honoraria for speaking on educational courses Non-profit entities: Rasmussen encephalitis children project (Mr Seth Wohlberg) for travel and lodging to two Rasmussen encephalitis workshops in the USA

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. for UCB

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. Epilepsy-Centre Bielefeld-Bethel, 100% clinical practice

    Research Support, Commercial Entities:

    1. (1) Fresenius Medical Care, Homburg, Germany (2) diamed, K?ln, Germany

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Academic entity University of Bonn, Dept. of Epileptology, Bonn, Germany (where I was employed until 31st Dec, 2010)

    Research Support, Foundations and Societies:

    1. Hagedorn Foundation Bielefeld

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. The Krankenhaus Mara gGmbH receives payment for antibody tests (antineural antibodies) performed in the laboratory run by CGB.

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (P.K., I.G., S.V., H.J.H., C.B.), University Clinic Magdeburg, Germany; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; Department of Psychiatry and Psychotherapy (C.M.S.), Charité University Hospital, Berlin, Germany; Department of Neuropathology (W.B.), University Medical Center Göttingen, Germany; Department of Neurology (F.R.W.), Median Clinic NRZ Magdeburg, Germany; and Epilepsy Center Bethel (C.G.B.), Krankenhaus Mara, Bielefeld, Germany.
  1. Correspondence to Dr. Körtvelyessy: peter.koertvelyessy{at}med.ovgu.de
View Full Text

Article usage

Article usage: February 2015 to October 2022

AbstractFullPdfSource
Feb 201527139Highwire
Mar 2015451811Highwire
Mar 201502819pmc
Apr 20151093029Highwire
Apr 201502211pmc
May 2015261469Highwire
May 20150219pmc
Jun 201511239Highwire
Jun 201501411pmc
Jul 201517810Highwire
Jul 20150105pmc
Aug 201554912Highwire
Aug 20150145pmc
Sep 2015960Highwire
Sep 2015082pmc
Oct 2015983Highwire
Oct 2015051pmc
Nov 2015775Highwire
Nov 20150108pmc
Dec 2015512Highwire
Dec 20150113pmc
Jan 20161250Highwire
Jan 2016091pmc
Feb 20162254Highwire
Feb 20160148pmc
Mar 20161542Highwire
Mar 201607910pmc
Apr 20162352Highwire
Apr 20160388pmc
May 2016940Highwire
May 20160193pmc
Jun 20162577Highwire
Jun 20160215pmc
Jul 20161364Highwire
Jul 20160239pmc
Aug 20162035Highwire
Aug 20160272pmc
Sep 20161714Highwire
Sep 20160184pmc
Oct 20162074Highwire
Oct 20160184pmc
Nov 20161225Highwire
Nov 20160161pmc
Dec 2016912Highwire
Dec 20160140pmc
Jan 20171413Highwire
Jan 20170154pmc
Feb 20171000Highwire
Feb 20170171pmc
Mar 2017910Highwire
Mar 20170195pmc
Apr 20171286Highwire
Apr 20170413pmc
May 20171160Highwire
May 20171820pmc
Jun 2017871Highwire
Jun 20174717pmc
Jul 2017872Highwire
Jul 20173716pmc
Aug 20171492Highwire
Aug 20172818pmc
Sep 2017611Highwire
Sep 20173514pmc
Oct 2017550Highwire
Oct 201761020pmc
Nov 2017731Highwire
Nov 20173718pmc
Dec 20173202Highwire
Jan 20184240Highwire
Feb 20185153Highwire
Mar 20182401Highwire
Apr 20185224Highwire
Apr 201841220pmc
May 20184368Highwire
Jun 20184324Highwire
Jun 201851224pmc
Jul 20182386Highwire
Aug 20182404Highwire
Aug 201821222pmc
Sep 20182324Highwire
Oct 20188306Highwire
Nov 20185401Highwire
Dec 20186372Highwire
Jan 20192292Highwire
Feb 20192317Highwire
Mar 20195186Highwire
Apr 201952916Highwire
May 201972011Highwire
Jun 201962710Highwire
Jul 20194197Highwire
Aug 20192237Highwire
Sep 20192159Highwire
Oct 20191198Highwire
Nov 201921810Highwire
Dec 201901515Highwire
Jan 202041914Highwire
Feb 20202106Highwire
Mar 20202208Highwire
Apr 2020463Highwire
May 20202109Highwire
Jun 2020064Highwire
Jul 20202714Highwire
Aug 2020163Highwire
Sep 20203136Highwire
Oct 2020199Highwire
Nov 20201715Highwire
Dec 202031213Highwire
Jan 202191619Highwire
Feb 20218510Highwire
Mar 202111114Highwire
Apr 202151617Highwire
May 202132012Highwire
Jun 20211159Highwire
Jul 202111320Highwire
Aug 202131510Highwire
Sep 20213136Highwire
Oct 202102117Highwire
Nov 202121418Highwire
Dec 20217196Highwire
Jan 20223188Highwire
Feb 20222183Highwire
Mar 20221212Highwire
Apr 20222208Highwire
May 202261517Highwire
Jun 2022194Highwire
Jul 2022293Highwire
Aug 20221203Highwire
Sep 202222114Highwire
Oct 202201910Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me